137 related articles for article (PubMed ID: 8280708)
1. A genetic approach to idiotypic vaccination.
Hawkins RE; Winter G; Hamblin TJ; Stevenson FK; Russell SJ
J Immunother Emphasis Tumor Immunol; 1993 Nov; 14(4):273-8. PubMed ID: 8280708
[TBL] [Abstract][Full Text] [Related]
2. A genetic approach to idiotypic vaccination for B cell lymphoma.
Stevenson FK; Zhu D; King CA; Ashworth LJ; Kumar S; Thompsett A; Hawkins RE
Ann N Y Acad Sci; 1995 Nov; 772():212-26. PubMed ID: 8546396
[TBL] [Abstract][Full Text] [Related]
3. Idiotypic vaccination against human B-cell lymphoma. Rescue of variable region gene sequences from biopsy material for assembly as single-chain Fv personal vaccines.
Hawkins RE; Zhu D; Ovecka M; Winter G; Hamblin TJ; Long A; Stevenson FK
Blood; 1994 Jun; 83(11):3279-88. PubMed ID: 8193363
[TBL] [Abstract][Full Text] [Related]
4. BCL1 lymphoma protection induced by idiotype DNA vaccination is entirely dependent on anti-idiotypic antibodies.
Cesco-Gaspere M; Benvenuti F; Burrone OR
Cancer Immunol Immunother; 2005 Apr; 54(4):351-8. PubMed ID: 15692846
[TBL] [Abstract][Full Text] [Related]
5. [The experimental study on idiotypic DNA vaccine against human B-cell lymphoma to induce antitumor immune response].
Zhong KL; Zhang WJ; Yuan Y; Wu Y; Zhang MW; Mao N
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):609-15. PubMed ID: 14706145
[TBL] [Abstract][Full Text] [Related]
6. Immunization with a recombinant adenovirus encoding a lymphoma idiotype: induction of tumor-protective immunity and identification of an idiotype-specific T cell epitope.
Armstrong AC; Dermime S; Allinson CG; Bhattacharyya T; Mulryan K; Gonzalez KR; Stern PL; Hawkins RE
J Immunol; 2002 Apr; 168(8):3983-91. PubMed ID: 11937555
[TBL] [Abstract][Full Text] [Related]
7. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract][Full Text] [Related]
8. Idiotypic DNA vaccines against B-cell lymphoma.
Stevenson FK; Zhu D; King CA; Ashworth LJ; Kumar S; Hawkins RE
Immunol Rev; 1995 Jun; 145():211-28. PubMed ID: 7590827
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumor protection.
Benvenuti F; Burrone OR; Efremov DG
Gene Ther; 2000 Apr; 7(7):605-11. PubMed ID: 10819576
[TBL] [Abstract][Full Text] [Related]
10. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
[TBL] [Abstract][Full Text] [Related]
11. Anti-idiotypic antibodies induced by genetic immunisation are directed exclusively against combined V(L)/V(H) determinants.
Benvenuti F; Burrone OR
Gene Ther; 2001 Oct; 8(20):1555-61. PubMed ID: 11704816
[TBL] [Abstract][Full Text] [Related]
12. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
Ciavarra RP; Vitetta ES; Forman J
J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
[TBL] [Abstract][Full Text] [Related]
13. Toward personalized immunotherapy for non-Hodgkin lymphoma: targeting the idiotypic immunoglobulin.
Armstrong AC; Cheadle EJ; Hawkins RE
BioDrugs; 2005; 19(5):289-97. PubMed ID: 16207070
[TBL] [Abstract][Full Text] [Related]
14. B-cell lymphoma idiotypes chimerized by gene targeting can induce tumor immunity.
Selmayr M; Menzel H; Kremer JP; Thierfelder S; Mocikat R
Cancer Gene Ther; 2000 Mar; 7(3):501-6. PubMed ID: 10766357
[TBL] [Abstract][Full Text] [Related]
15. Intraclonal variability of VH genes in follicular lymphoma patients who have received anti-idiotypic immunotherapy.
Yáñez R; Barrios Y; Cabrera R; Díaz-Espada F
J Immunother; 2006; 29(1):61-6. PubMed ID: 16365601
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic manipulation of the GAT idiotypic cascade. Immunization of C57BL/6 mice by BALB/c anti-idiotypes stimulates similar strain-specific V genes as the original antigen.
Corbet S; Hirn M; Roth C; Theze J; Fougereau M; Schiff C
J Immunol; 1988 Aug; 141(3):779-84. PubMed ID: 3135311
[TBL] [Abstract][Full Text] [Related]
17. Idiotypic vaccination as a treatment for a B cell lymphoma.
George AJ; Folkard SG; Hamblin TJ; Stevenson FK
J Immunol; 1988 Sep; 141(6):2168-74. PubMed ID: 3049800
[TBL] [Abstract][Full Text] [Related]
18. Cell-free production of scFv fusion proteins: an efficient approach for personalized lymphoma vaccines.
Kanter G; Yang J; Voloshin A; Levy S; Swartz JR; Levy R
Blood; 2007 Apr; 109(8):3393-9. PubMed ID: 17164345
[TBL] [Abstract][Full Text] [Related]
19. Failure of vaccination with idiotypic protein or DNA, (+/-IL-2), the depletion of regulatory T cells, or the blockade of CTLA-4 to prolong dormancy in mice with BCL1 lymphoma.
Pop LM; Smallshaw JE; Tucker TF; Stevenson FK; Vitetta ES
J Immunother; 2005; 28(6):525-34. PubMed ID: 16224269
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies.
Lundin KU; Hofgaard PO; Omholt H; Munthe LA; Corthay A; Bogen B
Blood; 2003 Jul; 102(2):605-12. PubMed ID: 12649166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]